Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Third Quarter of 2021
19/10 12:30
Company Announcement Net sales of DARZALEX ® in the third quarter of 2021 totaled USD 1,580 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. Copenhagen, Denmark; October 19 , 20 21 – Genmab A/S ( Nasdaq : GMAB) announced today that worldwide net trade sales of...